🇺🇸 Diltiazem HCl in United States

3,319 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Completed Suicide — 430 reports (12.96%)
  2. Dyspnoea — 428 reports (12.9%)
  3. Death — 353 reports (10.64%)
  4. Nausea — 344 reports (10.36%)
  5. Fatigue — 334 reports (10.06%)
  6. Diarrhoea — 303 reports (9.13%)
  7. Dizziness — 303 reports (9.13%)
  8. Asthenia — 295 reports (8.89%)
  9. Atrial Fibrillation — 269 reports (8.1%)
  10. Drug Ineffective — 260 reports (7.83%)

Source database →

Diltiazem HCl in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Diltiazem HCl approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Diltiazem HCl in United States?

National Institute of Allergy and Infectious Diseases (NIAID) is the originator. The local marketing authorisation holder may differ — check the official source linked above.